Acambis Smallpox Vaccine FDA Review Expected In Third Quarter 2003
Executive Summary
FDA will receive the BLA for Acambis' smallpox vaccine in the third quarter of 2003, well after over 200 mil. doses of the vaccine have been manufactured
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PS038915
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
PS038915
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.